19-33301848-GGGCGGCGGCGGC-GGGCGGCGGCGGCGGCGGC

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP3

The NM_004364.5(CEBPA):​c.561_566dupGCCGCC​(p.Pro188_Pro189dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000687 in 1,310,760 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. P189P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000060 ( 0 hom. )

Consequence

CEBPA
NM_004364.5 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.21

Publications

2 publications found
Variant links:
Genes affected
CEBPA (HGNC:1833): (CCAAT enhancer binding protein alpha) This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]
CEBPA-DT (HGNC:25710): (CEBPA divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_004364.5

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEBPANM_004364.5 linkc.561_566dupGCCGCC p.Pro188_Pro189dup disruptive_inframe_insertion Exon 1 of 1 ENST00000498907.3 NP_004355.2
CEBPANM_001287424.2 linkc.666_671dupGCCGCC p.Pro223_Pro224dup disruptive_inframe_insertion Exon 1 of 1 NP_001274353.1
CEBPANM_001287435.2 linkc.519_524dupGCCGCC p.Pro174_Pro175dup disruptive_inframe_insertion Exon 1 of 1 NP_001274364.1
CEBPANM_001285829.2 linkc.204_209dupGCCGCC p.Pro69_Pro70dup disruptive_inframe_insertion Exon 1 of 1 NP_001272758.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEBPAENST00000498907.3 linkc.561_566dupGCCGCC p.Pro188_Pro189dup disruptive_inframe_insertion Exon 1 of 1 6 NM_004364.5 ENSP00000427514.1
ENSG00000267727ENST00000587312.1 linkn.406_411dupGGCGGC non_coding_transcript_exon_variant Exon 2 of 2 3
CEBPA-DTENST00000718467.1 linkn.46+65_46+70dupGGCGGC intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.0000135
AC:
2
AN:
148062
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000669
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000196
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000602
AC:
7
AN:
1162698
Hom.:
0
Cov.:
32
AF XY:
0.00000704
AC XY:
4
AN XY:
568584
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
23048
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16996
East Asian (EAS)
AF:
0.0000417
AC:
1
AN:
23998
South Asian (SAS)
AF:
0.00
AC:
0
AN:
48148
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
26506
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3124
European-Non Finnish (NFE)
AF:
0.00000625
AC:
6
AN:
959900
Other (OTH)
AF:
0.00
AC:
0
AN:
45694
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000681731), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.389
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000135
AC:
2
AN:
148062
Hom.:
0
Cov.:
32
AF XY:
0.0000139
AC XY:
1
AN XY:
72100
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40992
American (AMR)
AF:
0.0000669
AC:
1
AN:
14940
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3398
East Asian (EAS)
AF:
0.000196
AC:
1
AN:
5092
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9160
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66410
Other (OTH)
AF:
0.00
AC:
0
AN:
2040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Feb 08, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.561_566dupGCCGCC variant (also known as p.P188_P189dup), located in coding exon 1 of the CEBPA gene, results from an in-frame duplication of GCCGCC at nucleotide positions 561 to 566. This results in the duplication of 2 extra residues (PP) between codons 188 and 189. This amino acid position is well conserved in available vertebrate species. Based on the available evidence, the clinical significance of this variant remains unclear.

Acute myeloid leukemia Uncertain:1
Oct 04, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.561_566dup, results in the insertion of 2 amino acid(s) of the CEBPA protein (p.Pro188_Pro189dup), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CEBPA-related conditions. ClinVar contains an entry for this variant (Variation ID: 937708). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.2
Mutation Taster
=88/12
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs746430067; hg19: chr19-33792754; API